Monday, December 11, 2017

Press release distribution, EDGAR filing, XBRL, regulatory filings

Visit booth #4831 to try the Molecule Blaster virtual reality game. エドワーズ、VR(バーチャルリアリティー)で除害装置の仕組みを仮想体験 <SEMICON Japan 2017> Verastem Announces Clinical Data from the Pivotal Phase 3 DUO Study: Duvelisib Significantly Improves Progression Free Survival in Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma )--Verastem, Inc. , focused on discovering and developing drugs to improve the survival and quality of life of cancer patients, today announced the presentation ... bluebird bio Announces Updated Clinical Results from Ongoing Phase 1 Multicenter Study of LentiGlobin Gene Therapy in Severe Sickle Cell Disease at ... (more)

No comments:

Post a Comment